Pituitary Forte NDC 43857-0006

NDC codes

FDA NDC Directory

Product NDC (as listed)43857-0006Labeler and product segments. Claims need a package NDC.

Product NDC at billing width43857-0006Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
43857-0006-1	43857000601	30 mL in 1 BOTTLE, SPRAY (43857-0006-1)Marketed from Jun 9, 2016

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Pituitary Forte
Generic name (nonproprietary): hypophysis suis, hypothalamus (suis), pineal (suis)
Active ingredients: Sus scrofa hypothalamus — 8 [hp_X]/mLSus scrofa pineal gland — 8 [hp_X]/mLSus scrofa pituitary gland, Posterior — 8 [hp_X]/mL
Dosage form: Spray
Route: Oral
Labeler: BioActive Nutritional, Inc.
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: Apr 17, 2012
Marketing end: Feb 2, 2029
Identifiers: Product ID 43857-0006_93a4ce5a-7deb-41de-816e-03279a92ce80SPL ID 93a4ce5a-7deb-41de-816e-03279a92ce80SPL set ID 368cb9d0-4d56-485e-a759-42fa8b1081b9UNII N6R0856Z79, 050QZ2EDK7, E8S87O660T

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N443857000601 followed by a unit qualifier and the quantity

Package 43857-0006-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 19, 2025.

Indications (excerpt from the label)

INDICATIONS: For temporary relief of symptoms due to hypothalamic/pituitary dysregulation.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)